<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01623934</url>
  </required_header>
  <id_info>
    <org_study_id>GEN3G</org_study_id>
    <nct_id>NCT01623934</nct_id>
  </id_info>
  <brief_title>Role of Adipokines in Glucose Regulation During Pregnancy and in Fetal Development</brief_title>
  <acronym>GEN3G</acronym>
  <official_title>Role of Adipokines in Glucose Regulation During Pregnancy and in Fetal Development</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université de Sherbrooke</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fonds de la Recherche en Santé du Québec</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Université de Sherbrooke</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study includes 2 phases. During phase 1, pregnant women are followed over the course of
      pregnancy. The phase 2 is a follow-up of the mother-child dyad at 3 and 5 year after
      delivery.

      The purpose of this phase 1 is to :

        -  assess the contribution and interactions of adipokines in the development of insulin
           resistance during pregnancy and gestational diabetes;

        -  assess levels of maternal adipokines as determinants of development and fetal growth;

        -  determine the genetic variations that influence levels of adipokines and glucose
           regulation during pregnancy and in newborns.

      The purpose of this phase 2 is to:

        -  identify DNA methylation variations at birth that are predictive of childhood
           overweight/obesity.

        -  identify maternal characteristics associated with DNA methylation variations predictive
           of childhood overweight/obesity.

        -  establish whether the loci predictive of childhood overweight/obesity at birth are still
           differentially methylated at 5 years of age (samples collected at 5 years of age).

        -  identify DNA methylation variations at birth that are predictive of childhood
           neurodevelopment problems at 3 and 5 years of age.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnosis of gestational diabetes mellitus</measure>
    <time_frame>24-28 weeks of gestation</time_frame>
    <description>75g oral glucose tolerance test</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1086</enrollment>
  <condition>Gestational Diabetes</condition>
  <condition>Insulin Resistance</condition>
  <arm_group>
    <arm_group_label>Phase 1: Pregnant women</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase 2: Mother-offspring dyad</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      plasma, whole cord blood, serum cord blood, white cells, sample of placenta
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women when they come for their first prenatal visit at the Clinique de
        Prélèvements et de Recherche en Grossesse.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age ≥ 18 yrs

          -  gestational age between 6 and 13 weeks from last menstrual period

          -  no recognized diabetes or drugs interfering with glucose metabolism

          -  alcohol &lt; 2 drinks/day

          -  not involved in regular high intensity physical activity

          -  otherwise good health status

        Exclusion Criteria:

          -  twin pregnancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marie-France Hivert, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université de Sherbrooke</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre de recherche Étienne-Le Bel, Centre hospitalier universitaire de Sherbrooke</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1H5N4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2012</study_first_submitted>
  <study_first_submitted_qc>June 18, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 20, 2012</study_first_posted>
  <last_update_submitted>May 1, 2017</last_update_submitted>
  <last_update_submitted_qc>May 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Université de Sherbrooke</investigator_affiliation>
    <investigator_full_name>Marie-France Hivert</investigator_full_name>
    <investigator_title>Md, MMSc</investigator_title>
  </responsible_party>
  <keyword>Gestational diabetes</keyword>
  <keyword>Adiponectin</keyword>
  <keyword>Leptin</keyword>
  <keyword>Single Nucleotides Polymorphisms</keyword>
  <keyword>Insulin resistance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Diabetes, Gestational</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

